References
1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81. [
PubMed]
2. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94(1):26–34.[
PMC free article] [
PubMed]
3. Townsend K, et al. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol. 2005;97(1-2):103–9.[
PubMed]
4. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev.2005;26(5):662–87. [
PubMed]
5. Wu S, et al. Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology. 2007;148(7):3410–8. [
PubMed]
6. van Etten E, et al. Regulation of vitamin D homeostasis: implications for the immune system. Nutr Rev.2008;66(10 Suppl 2):S125–34. [
PubMed]
7. Williams C. On the use and administration of cod-liver oil in pulmonary consumption. London Journal of Medicine. 1849;1:1–18.
8. Ginde AA, Mansbach JM, Camargo CA., Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169(4):384–90. [
PMC free article] [
PubMed]
9. Laaksi I, et al. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr. 2007;86(3):714–7. [
PubMed]
10. Cannell JJ, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134(6):1129–40.[
PMC free article] [
PubMed]
11. Bodnar LM, Krohn MA, Simhan HN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr. 2009;139(6):1157–61. [
PMC free article] [
PubMed]
12. Villamor E. A potential role for vitamin D on HIV infection? Nutr Rev. 2006;64(5 Pt 1):226–33.[
PubMed]
13. Rodriguez M, et al. High frequency of vitamin D deficiency in ambulatory HIV-Positive patients. AIDS Res Hum Retroviruses. 2009;25(1):9–14. [
PubMed]
14. Yamshchikov AV, et al. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract. 2009;15(5):438–49. [
PMC free article] [
PubMed]
15. Urashima M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91(5):1255–60. [
PubMed]
16. Gallo RL, et al. Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol. 2002;110(6):823–31. [
PubMed]
17. Liu PT, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770–3. [
PubMed]
18. Wang TT, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5):2909–12. [
PubMed]
19. Liu PT, et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One. 2009;4(6):e5810. [
PMC free article] [
PubMed]
20. Adorini L. Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol.2005;233(2):115–24. [
PubMed]
21. Munger KL, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA.2006;296(23):2832–8. [
PubMed]
22. Littorin B, et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) Diabetologia. 2006;49(12):2847–52. [
PubMed]
23. Merlino LA, et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum. 2004;50(1):72–7. [
PubMed]
24. Fronczak CM, et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care. 2003;26(12):3237–42. [
PubMed]
25. Zold E, et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther.2008;10(5):R123. [
PMC free article] [
PubMed]
26. Kamen D, Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol.2008;20(5):532–7. [
PubMed]
27. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009;132(Pt 5):1146–60. [
PubMed]
28. Smolders J, et al. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler. 2008;14(9):1220–4. [
PubMed]
29. Craig SM, et al. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol. 2010;37(2):275–81. [
PMC free article][
PubMed]
30. Patel S, et al. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007;56(7):2143–9. [
PubMed]
31. Lemire JM, et al. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest. 1984;74(2):657–61.[
PMC free article] [
PubMed]
32. Chen S, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179(3):1634–47. [
PubMed]
33. Bhalla AK, et al. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol.1984;133(4):1748–54. [
PubMed]
34. Mattner F, et al. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3) Eur J Immunol. 2000;30(2):498–508. [
PubMed]
35. Boonstra A, et al. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001;167(9):4974–80. [
PubMed]
36. Tang J, et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol. 2009;182(8):4624–32. [
PMC free article] [
PubMed]
37. Daniel C, et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 2008;324(1):23–33. [
PubMed]
38. Gregori S, et al. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 2001;167(4):1945–53. [
PubMed]
Fick inte plats med fler, men det fanns 62 referenser till studien.